These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3421274)

  • 1. Early versus late tocolytic treatment for preterm premature membrane rupture.
    Bourgeois FJ; Harbert GM; Andersen WA; Thiagarajah S; Duffer J; Hendrickx K
    Am J Obstet Gynecol; 1988 Sep; 159(3):742-8. PubMed ID: 3421274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocolysis does not improve neonatal outcome in patients with preterm rupture of membranes.
    Jazayeri A; Jazayeri MK; Sutkin G
    Am J Perinatol; 2003 May; 20(4):189-93. PubMed ID: 12874729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature rupture of the membranes--aggressive versus conservative approach: effect of tocolytic and antibiotic therapy.
    Matsuda Y; Ikenoue T; Hokanishi H
    Gynecol Obstet Invest; 1993; 36(2):102-7. PubMed ID: 8225043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tocolytic therapy with magnesium sulfate and terbutaline for inhibition of premature labor].
    Jiménez Aramayo JF; Jiménez Martinez F; López Rosales C
    Ginecol Obstet Mex; 1990 Sep; 58():265-9. PubMed ID: 2276652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tocolytic use in the management of symptomatic placenta previa.
    Besinger RE; Moniak CW; Paskiewicz LS; Fisher SG; Tomich PG
    Am J Obstet Gynecol; 1995 Jun; 172(6):1770-5; discussion 1775-8. PubMed ID: 7778631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery.
    Spisso KR; Harbert GM; Thiagarajah S
    Am J Obstet Gynecol; 1982 Apr; 142(7):840-5. PubMed ID: 7065062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study on the effects of steroid administration and prolongation of the latent phase in patients with preterm premature rupture of the membranes.
    Arias F; Knight AB; Tomich PB
    Am J Obstet Gynecol; 1986 May; 154(5):1059-63. PubMed ID: 3706431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for tocolytic therapy during conservative management of preterm premature rupture of the membranes?
    Mercer BM
    Clin Obstet Gynecol; 2007 Jun; 50(2):487-96. PubMed ID: 17513934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes.
    Weiner CP; Renk K; Klugman M
    Am J Obstet Gynecol; 1988 Jul; 159(1):216-22. PubMed ID: 3134815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
    Wenstrom KD; Weiner CP; Merrill D; Niebyl J
    Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of residual amniotic fluid volume in patients receiving parenteral tocolysis after premature rupture of the membranes.
    Silver RK; MacGregor SN; Hobart ED
    Am J Obstet Gynecol; 1989 Sep; 161(3):784-7. PubMed ID: 2675610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients.
    Kosasa TS; Busse R; Wahl N; Hirata G; Nakayama RT; Hale RW
    Obstet Gynecol; 1994 Sep; 84(3):369-73. PubMed ID: 8058233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does magnesium sulfate delay the active phase of labor in women with premature rupture of membranes? A randomized controlled trial.
    Mirzamoradi M; Behnam M; Jahed T; Saleh-Gargari S; Bakhtiyari M
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):309-12. PubMed ID: 25286782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. A preliminary report.
    Miller JM; Keane MW; Horger EO
    J Reprod Med; 1982 Jun; 27(6):348-51. PubMed ID: 7120214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of conservative management of premature rupture of the membranes.
    Andreyko JL; Chen CP; Shennan AT; Milligan JE
    Am J Obstet Gynecol; 1984 Mar; 148(5):600-4. PubMed ID: 6702923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor.
    Caritis SN; Toig G; Heddinger LA; Ashmead G
    Am J Obstet Gynecol; 1984 Sep; 150(1):7-14. PubMed ID: 6383045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed delivery of a triplet pregnancy without surgical intervention: a case report.
    Ziegler WF; Welgoss J
    Am J Perinatol; 1996 Apr; 13(3):191-3. PubMed ID: 8688114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study.
    Cotton DB; Strassner HT; Hill LM; Schifrin BS; Paul RH
    J Reprod Med; 1984 Feb; 29(2):92-7. PubMed ID: 6708033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.